Back Login for AI Analysis

    APGE (STOCKS)

    Apogee Therapeutics, Inc. Common Stock

    $65.810000
    +0.310000 (+0.47%)
    Prev close: $65.500000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Michael Henderson
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $4,736.69M
    Employees
    196
    P/E (TTM)
    -15.24
    P/B (TTM)
    8.13
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    10
    Strong Buy
    9
    Buy
    3
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Sep 2025 (Q3)
    $-1.11 $-1.21 +0.1027 +8.47%
    Jun 2025 (Q2)
    $-1.13 $-1.10 -0.0320 -2.91%
    Mar 2025 (Q1)
    $-0.95 $-1.27 +0.3227 +25.36%
    Dec 2024 (Q4)
    $-1.19 $-1.10 -0.0923 -8.41%
    Financial Statements
    TTM (Sep 2025)
    Assets $626.16M
    Current Assets $540.10M
    Prepaid Expenses $7.41M
    Other Current Assets $532.69M
    Noncurrent Assets $86.06M
    Fixed Assets $6.03M
    Other Non-current Assets $80.03M
    Liabilities $39.82M
    Current Liabilities $34.05M
    Accounts Payable $376.00K
    Wages $12.68M
    Other Current Liabilities $20.99M
    Noncurrent Liabilities $5.77M
    Equity $586.34M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $586.34M
    Liabilities And Equity $626.16M